Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services | News
Search Refinements

Contract Services News

View news from other Pharmaceutical sectors:
91-105 of 2364 results
Aspen to buy rights to AstraZeneca’s global anaesthetics portfolio outside US
By PBR Staff Writer
Aspen Global Incorporated (AGI) has agreed to acquire AstraZeneca’s worldwide anaesthetics portfolio, excluding the US, for about $520m.
Contract Research & Services > Contract Services > News
CRISPR gains license to Anagenesis’ P2MCs technology for cell therapy for muscle diseases
CRISPR Therapeutics and Anagenesis Biotechnologies announced a strategic in-licensing and collaboration agreement, which grants CRISPR Therapeutics exclusive worldwide license to Anagenesis’ Paraxial Mesoderm Multipotent Cells (P2MCs) technology for cell therapy for all human muscle diseases.
Contract Research & Services > Contract Services > News
ViiV Healthcare signs public tender deal with Botswana Ministry of Health for dolutegravir
ViiV Healthcare, a global specialist HIV company majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, confirmed a public tender agreement with the Ministry of Health in Botswana to support the implementation of a new national ‘Treat All’ programme which aims to ensure people living with HIV in the country get tested and receive treatment.
Contract Research & Services > Contract Services > News
ARIAD completes sale of European operations and out-license of European rights to Iclusig
ARIAD Pharmaceuticals has completed the sale of its European operations to Incyte and entered into the previously announced license agreement for Incyte to exclusively license Iclusig (ponatinib) in Europe and other select countries.
Contract Research & Services > Contract Services > News
AstraZeneca agrees to sell Zurampic's European & Latin American rights to Grunenthal
By PBR Staff Writer
AstraZeneca has agreed to license exclusive rights to the gout-associated hyperuricemia drug Zurampic (lesinurad) in Europe and Latin America to Grünenthal.
Contract Research & Services > Contract Services > News
Lipidor, Cadila sign deal on joint commercialization of topical Psoriasis product
Lipidor and Cadila Pharmaceuticals have entered into a collaboration agreement on the commercialization of a sprayable anti-psoriatic product consisting of the generic Vitamin D analogue, Calcipotriol, formulated with Lipidor´s patented lipid-based drug delivery technology, AKVANO.
Contract Research & Services > Contract Services > News
Genmab to receive $30m milestone payment from Janssen in Darzalex collaboration
By PBR Staff Writer
Danish biotechnology firm Genmab will receive $30m payment from Janssen Biotech under Darzalex (daratumumab) collaboration.
Contract Research & Services > Contract Services > News
TG Therapeutics enters into global collaboration to develop Jubilant's novel BET inhibitor program
TG Therapeutics unveiled that as part of a broader agreement with Indian biotechnology firm Jubilant Biosys, it has entered into a sub-license agreement with Checkpoint Therapeutics to develop and commercialize Jubilant's novel BET inhibitor program in the field of hematological malignancies.
Contract Research & Services > Contract Services > News
PDL BioPharma commits to equity investment in Noden Pharma
PDL BioPharma has committed to an equity investment in Noden Pharma DAC, a new privately held company that has executed a purchase agreement with Novartis to acquire exclusive worldwide rights to manufacture, market, and sell the branded prescription medicine product sold under the name Tekturna and Tekturna HCT in the US and Rasilez and Rasilez HCT in the rest of the world.
Contract Research & Services > Contract Services > News
BioPharma Services wins $20m contract from FDA's Center for Drug Evaluation and Research
BioPharma Services USA, Inc. (BioPharma) has been awarded a 5-year, $20m contract with the Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA).
Contract Research & Services > Contract Services > News
MacroGenics, Janssen partner to develop new DART molecule for cancer treatment
By PBR Staff Writer
MacroGenics has licensed its preclinical cancer therapy MGD015 to Janssen Biotech under a global collaboration that may generate nearly $740m for the clinical-stage biopharmaceutical firm.
Contract Research & Services > Contract Services > News
McKesson and Walmart sign sourcing deal for generic pharmaceuticals
McKesson and Wal-Mart Stores have signed a sourcing agreement for generic pharmaceuticals and an expanded long-term distribution agreement.
Contract Research & Services > Contract Services > News
Biogen collaborates with University of Pennsylvania on multiple gene therapy programs
Biogen announced a broad collaboration and alliance with the University of Pennsylvania (“Penn”) to advance gene therapy and gene editing technologies.
Contract Research & Services > Contract Services > News
Sunshine Biopharma signs licensing deal for Anastrozole drug to treat breast cancer
Sunshine Biopharma has signed a Cross Referencing Agreement with a major pharmaceutical company for Anastrozole, a prescription generic drug for treatment of Breast Cancer.
Contract Research & Services > Contract Services > News
BioDelivery Sciences grants exclusive rights to develop ONSOLIS in US to Collegium
BioDelivery Sciences International (BDSI) has granted the exclusive rights to develop and commercialize ONSOLIS (fentanyl buccal soluble film) in the US to Collegium Pharmaceutical.
Contract Research & Services > Contract Services > News
91-105 of 2364 results